Loading stock data...
Processa Pharmaceuticals, Inc. (PCSA) Stock Price, Chart & Analysis
Processa Pharmaceuticals, Inc.PCSA
Market Open$0.22
$-0.00-0.27%
PCSA Market Indicators
Very Bearish
Market Sentiment
Historical Price Chart
View the historical price chart for PCSA to analyze trends and spot opportunities. Use our interactive chart to compare past performance and make informed decisions.
Processa Pharmaceuticals, Inc. (PCSA)
Loading chart data...
Is Processa Pharmaceuticals, Inc. (PCSA) Stock a Buy in 2025?
YES
BUY
Score: 79/100
Yes, PCSA stock appears to be a good buy in 2025 based on our comprehensive analysis.
Comprehensive analysis of whether PCSA stock is a good investment in 2025, including growth drivers, valuation metrics, risk factors, and analyst recommendations.
Growth Drivers
- Healthcare sector momentum
Valuation Considerations
- Analyst price targets suggest 799.3% upside potential
- Small-cap with higher growth potential and volatility
Risk Factors
- Healthcare sector cyclicality
- Small-cap liquidity and volatility risks
Analyst Consensus
Buy Ratings:0
Hold Ratings:1
Sell Ratings:0
Avg. Price Target:$2.00
Upside Potential:799.3%
Investment Summary
PCSA presents a mixed investment profile for 2025. The company shows strong growth drivers including healthcare sector momentum, though analyst price targets suggest 799.3% upside potential.
Analyst sentiment is mixed with 0 buy ratings vs 0 sell ratings.
Investors should weigh the growth potential against the identified risks, particularly healthcare sector cyclicality, and consider their own risk tolerance and investment timeline.
Final Recommendation
BUY
Recommendation Score
Overall Score:79/100
Strong Buy
Key Factors
- Very significant upside potential
- Moderate analyst consensus
- Low debt levels
- Small-cap risks
- Very low debt relative to market cap
- Debt-to-Market-Cap Ratio: 0.3% (Very Low)
Investment Decision
Based on our comprehensive analysis of PCSA's financial metrics, growth prospects, valuation, analyst sentiment, and risk factors, we recommend a BUY. This recommendation considers the company's current fundamentals, market position, and future growth potential while accounting for identified risks and market conditions.
How to Invest in pcsa Stock?
Quick Investment Insights for pcsa
High Volatility (Beta: 1.31)
1. Research Fundamentals
Analyze financial statements and market position
2. Technical Analysis
Review price charts and technical indicators
3. Risk Assessment
Evaluate market and company-specific risks
Company Profile
Processa Pharmaceuticals, Inc.
Healthcare
Biotechnology
Processa Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops chemotherapy drugs to improve the safety and efficacy of cancer treatment. Its drugs are modifications of existing ...
Employees
10
Market Cap
$8.96M